Skip to main content

Advertisement

SpringerLink
Log in

Prevalence and incidence of systemic lupus erythematosus in South Korea

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to estimate the nationwide prevalence and incidence of systemic lupus erythematosus (SLE) in South Korea. National Health Insurance claims data covering almost all Koreans (~50 million) during 2006–2010 were analyzed. Individuals with SLE were identified if (1) they had experienced at least one hospitalization for SLE (International Classification of Diseases, 10th revision code M32), (2) they had taken at least one concomitant prescription of immunosuppressant and hydroxychloroquine, or (3) they had taken anti-dsDNA antibody (≥2) or complement tests (≥2) during each calendar year. Incident cases were defined only if they had not been SLE prevalent for the preceding 2 years and had been SLE prevalent for 2 years consecutively thereafter. The annual prevalence (per 100,000) increased slightly from 20.6 [95 % confidence interval (95 % CI) 20.2–21.0] in 2006 to 26.5 (95 % CI 26.0–27.0) in 2010, and the incidence (per 100,000) ranged between 2.5 (95 % CI 2.4–2.6) in 2008 and 2.8 (95 % CI 2.7–2.9) in 2009. The number of SLE-prevalent female patients outnumbered SLE-prevalent male patients by approximately sixfold, with a female-to-male incidence ratio of ~9:1. The prevalence and incidence of SLE increased significantly with age, regardless of sex, to a peak the age of 30–39 years. However, while both of them significantly decreased thereafter in females, this tendency was not observed in males.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cassano G, Roverano S, Paira S, Bellomio V, Lucero E, Berman A et al (2007) Accrual of organ damage over time in Argentine patients with systemic lupus erythematosus: a multi-centre study. Clin Rheumatol 26:2017–2022

    Article  PubMed  Google Scholar 

  2. Merrell M, Shulman LE (1955) Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis 1:12–32

    Article  CAS  PubMed  Google Scholar 

  3. Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS (2008) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 39:257–268

    Article  Google Scholar 

  4. Bongu A, Chang E, Ramsey-Goldman R (2002) Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol 16:313–332

    Article  PubMed  Google Scholar 

  5. Lau CS, Mak A (2009) The socioeconomic burden of SLE. Nat Rev Rheumatol 5:400–404

    Article  PubMed  Google Scholar 

  6. Slawsky KA, Fernandes AW, Fusffld L, Manzi S, Goss TF (2011) A structured literature review of the direct costs of adult systemic lupus erythematosus in the US. Arthritis Care Res 63:1224–1232

    Article  Google Scholar 

  7. Danchenko N, Satia JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15:308–318

    Article  CAS  PubMed  Google Scholar 

  8. Hochberg MC, Perlmutter DL, Medsger TA, Steen V, Weisman MH, White B et al (1995) Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 4:454–456

    Article  CAS  PubMed  Google Scholar 

  9. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O’Fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 42:46–50

    Article  CAS  PubMed  Google Scholar 

  10. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 56:2092–2094

    Article  PubMed Central  PubMed  Google Scholar 

  11. Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcon GS et al (2013) Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000–2004. Arthritis Rheum 65:753–763

    Article  PubMed Central  PubMed  Google Scholar 

  12. Furst DE, Clarke AE, Fernandes AW, Bancroft T, Greth W, Iorga SR (2013) Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population. Lupus 22:99–105

    Article  CAS  PubMed  Google Scholar 

  13. Hiraki LT, Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC et al (2012) Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum 64:2669–2676

    Article  PubMed Central  PubMed  Google Scholar 

  14. Lerang K, Gilboe I, Garen T, Thelle DS, Gran JT (2012) High incidence and prevalence of systemic lupus erythematosus in Norway. Lupus 21:1362–1369

    Article  CAS  PubMed  Google Scholar 

  15. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J (1991) High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 50:490–492

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N (2012) Systematic review of the epidemiology of systemic lupus erythematosus in the Asia–Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res 64:159–168

    Article  Google Scholar 

  17. Health Insurance Review and Assessment Service, National Health Insurance Service (2012) 2011 National Health Insurance statistical yearbook (in Korean). Available from: http://www.nhic.or.kr. Accessed 4 Dec 2013

  18. National Health Insurance Corporation, Health Insurance Policy Research Institute (2010) Research report on health care utilization of patients with rare and intractable disorder and improvement of individual copayment beneficiaries program for rare and intractable disorder (in Korean). Available from: http://www.nhic.or.kr. Accessed 4 Dec 2013

  19. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  CAS  PubMed  Google Scholar 

  20. Ward MM (2004) Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health 13:713–718

    Article  Google Scholar 

  21. Naleway AL, Davis ME, Greenlee RT, Wilson DA, McCarty DJ (2005) Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 14:862–866

    Article  CAS  PubMed  Google Scholar 

  22. Barnabe C, Joseph L, Belisle P, Labrecque J, Edworthy S, Barr SG et al (2012) Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care Res 64:138–143

    Article  Google Scholar 

  23. Peschken CA, Esdaile JM (2000) Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol 27:1884–1891

    CAS  PubMed  Google Scholar 

  24. Molina MJ, Mayor AM, Franco AE, Morell CA, Lopez MA, Vila LM (2007) Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico. J Clin Rheumatol 13:202–204

    Article  PubMed Central  PubMed  Google Scholar 

  25. Xiang YJ, Dai SM (2009) Prevalence of rheumatic diseases and disability in China. Rheumatol Int 29:481–490

    Article  PubMed  Google Scholar 

  26. Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R et al (2008) Rheumatic diseases in China. Arthritis Res Ther 10:R17

    Article  PubMed Central  PubMed  Google Scholar 

  27. Mok CC, To CH, Ho LY, Yu KL (2008) Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000–2006. J Rheumatol 35:1978–1982

    PubMed  Google Scholar 

  28. Yeh KW, Yu CH, Chan PC, Horng JT, Huang JL (2013) Burden of systemic lupus erythematosus in Taiwan: a population-based survey. Rheumatol Int 33:1805–1811

    Article  PubMed  Google Scholar 

  29. Iseki K, Miyasato F, Oura T, Uehara H, Nishime K, Fukiyama K (1994) An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 23:547–554

    Article  CAS  PubMed  Google Scholar 

  30. Hopkinson ND, Doherty M, Powell RJ (1993) The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989–1990. Br J Rheumatol 32:110–115

    Article  CAS  PubMed  Google Scholar 

  31. Johnson AE, Gordon C, Palmer RG, Bacon PA (1995) The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 38:551–558

    Article  CAS  PubMed  Google Scholar 

  32. Nightingale AL, Farmer RD, de Vries CS (2007) Systemic lupus erythematosus prevalence in the UK: methodological issues when using the general practice research database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiol Drug Saf 16:144–151

    Article  CAS  PubMed  Google Scholar 

  33. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G (2000) Incidence studies of systemic lupus erythematosus in southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 27:685–691

    CAS  PubMed  Google Scholar 

  34. Alonso MD, Llorca J, Martinez-Vazquez F, Miranda-Filloy JA, Diaz de Teran T, Dierssen T et al (2011) Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study. Medicine (Baltimore) 90:350–358

    Google Scholar 

  35. Laustrup H, Voss A, Green A, Junker P (2009) Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study. Scand J Rheumatol 38:128–132

    Article  CAS  PubMed  Google Scholar 

  36. Govoni M, Castellino G, Bosi S, Napoli N, Trotta F (2006) Incidence and prevalence of systemic lupus erythematosus in a district of north Italy. Lupus 15:110–113

    Article  CAS  PubMed  Google Scholar 

  37. Alamanos Y, Voulgari PV, Siozos C, Katsimpri P, Tsintzos S, Dimou G et al (2003) Epidemiology of systemic lupus erythematosus in northwest Greece 1982–2001. J Rheumatol 30:731–735

    PubMed  Google Scholar 

  38. Nightingale AL, Farmer RD, de Vries CS (2006) Incidence of clinically diagnosed systemic lupus erythematosus 1992–1998 using the UK general practice research database. Pharmacoepidemiol Drug Saf 15:656–661

    Article  PubMed  Google Scholar 

  39. Uribe AG, McGwin G Jr, Reveille JD, Alarcón GS (2004) What have we learned from a 10-year experience with the LUMINA (lupus in minorities; nature vs. nurture) cohort? Where are we heading? Autoimmun Rev 3:321–329

    Article  PubMed  Google Scholar 

  40. Bae SC, Fraser P, Liang MH (1998) The epidemiology of systemic lupus erythematosus in populations of African ancestry. Arthritis Rheum 41:2091–2099

    Article  CAS  PubMed  Google Scholar 

  41. Shapira Y, Agmon-Levin A, Shoenfeld Y (2010) Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 6:468–476

    Article  CAS  PubMed  Google Scholar 

  42. Baker SB, Rovira JR, Campion EW, Mills JA (1979) Late onset systematic lupus erythematosus. Am J Med 66:727–732

    Article  CAS  PubMed  Google Scholar 

  43. National Health Insurance Corporation (2008) Strategies to construct a cohort of health examinee: development of strategies of evaluating validity (in Korean). Available from: http://www.nhic.or.kr. Accessed 4 Dec 2013

  44. Park BJ, Sung JH, Park KD, Suh SW, Kim SW (2003) Strategies to improve the validity of diagnostic codes of National Health Insurance claims data and to utilize the data. Seoul National University College of Medicine, Seoul (in Korean)

  45. Osio-Salido E, Manapat-Reyes H (2010) Epidemiology of systemic lupus erythematosus in Asia. Lupus 19:1365–1367

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by grants from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A080588 and A120404).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, 133-792, South Korea

    Jee-Seon Shim, Yoon-Kyoung Sung, Young Bin Joo, Hye-Soon Lee & Sang-Cheol Bae

Authors
  1. Jee-Seon Shim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoon-Kyoung Sung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Young Bin Joo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hye-Soon Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sang-Cheol Bae
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sang-Cheol Bae.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 50 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shim, JS., Sung, YK., Joo, Y.B. et al. Prevalence and incidence of systemic lupus erythematosus in South Korea. Rheumatol Int 34, 909–917 (2014). https://doi.org/10.1007/s00296-013-2915-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-013-2915-9

Keywords

Search

Navigation